Table of Contents
Molecular Biology International
Volume 2015, Article ID 698169, 8 pages
http://dx.doi.org/10.1155/2015/698169
Review Article

Systems Medicine: The Application of Systems Biology Approaches for Modern Medical Research and Drug Development

1Centre for Molecular Medicine and Biobanking, University of Malta, Msida MSD 2080, Malta
2Faculty of Medical & Human Sciences, The University of Manchester, Oxford Road, Manchester M13 9PL, UK

Received 31 May 2015; Revised 27 July 2015; Accepted 29 July 2015

Academic Editor: Andrzej Kloczkowski

Copyright © 2015 Duncan Ayers and Philip J. Day. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. D. Mesarovic, S. N. Sreenath, and J. D. Keene, “Search for organising principles: understanding in systems biology,” Systems Biology, vol. 1, no. 1, pp. 19–27, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. F. J. Bruggeman and H. V. Westerhoff, “The nature of systems biology,” Trends in Microbiology, vol. 15, no. 1, pp. 45–50, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Friboulet and D. Thomas, “Systems biology—an interdisciplinary approach,” Biosensors and Bioelectronics, vol. 20, no. 12, pp. 2404–2407, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. T. Tillmann, A. R. Gibson, G. Scott, O. Harrison, A. Dominiczak, and P. Hanlon, “Systems medicine 2.0: potential benefits of combining electronic health care records with systems science models,” Journal of Medical Internet Research, vol. 17, no. 3, 2015. View at Publisher · View at Google Scholar
  5. S. A. Bustin, V. Benes, J. A. Garson et al., “The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments,” Clinical Chemistry, vol. 55, no. 4, pp. 611–622, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Brazma, “Minimum information about a microarray experiment (MIAME)—successes, failures, challenges,” TheScientificWorldJournal, vol. 9, pp. 420–423, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. A. C. Kaushik and S. Sahi, “Boolean network model for GPR142 against Type 2 diabetes and relative dynamic change ratio analysis using systems and biological circuits approach,” Systems and Synthetic Biology, vol. 9, no. 1-2, pp. 45–54, 2015. View at Publisher · View at Google Scholar
  8. P. Cardinal-Fernández, N. Nin, J. Ruíz-Cabello, and J. A. Lorente, “Systems medicine: a new approach to clinical practice,” Archivos de Bronconeumologia, vol. 50, no. 10, pp. 444–451, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. T. Kamada, “System biomedicine: a new paradigm in biomedical engineering,” Frontiers of Medical and Biological Engineering, vol. 4, no. 1, pp. 1–2, 1992. View at Google Scholar
  10. J. H. Karnes, S. V. Driest, E. A. Bowton et al., “Using systems approaches to address challenges for clinical implementation of pharmacogenomics,” Wiley Interdisciplinary Reviews: Systems Biology and Medicine, vol. 6, no. 2, pp. 125–135, 2014. View at Publisher · View at Google Scholar
  11. J. Zou, M.-W. Zheng, G. Li, and Z.-G. Su, “Advanced systems biology methods in drug discovery and translational biomedicine,” BioMed Research International, vol. 2013, Article ID 742835, 8 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Q. Zhang, W. K. Ching, N. K. Tsing, H. Y. Leung, and D. Guo, “A new multiple regression approach for the construction of genetic regulatory networks,” Artificial Intelligence in Medicine, vol. 48, no. 2-3, pp. 153–160, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. A. A. de Graaf, A. P. Freidig, B. De Roos et al., “Nutritional systems biology modeling: from molecular mechanisms to physiology,” PLoS Computational Biology, vol. 5, no. 11, Article ID e1000554, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. P. D. Karp, S. M. Paley, M. Krummenacker et al., “Pathway tools version 13.0: integrated software for pathway/genome informatics and systems biology,” Briefings in Bioinformatics, vol. 11, no. 1, pp. 40–79, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. K. Wolstencroft, S. Owen, O. Krebs et al., “SEEK: a systems biology data and model management platform,” BMC Systems Biology, vol. 9, no. 1, article 33, 2015. View at Publisher · View at Google Scholar
  16. P. Balazki, K. Lindauer, J. Einloft, J. Ackermann, and I. Koch, “MONALISA for stochastic simulations of Petri net models of biochemical systems,” BMC Bioinformatics, vol. 16, no. 1, 2015. View at Publisher · View at Google Scholar
  17. M. J. Araúzo-Bravo, Computational Biology Methods for Characterization of Pluripotent Cells, Methods in Molecular Biology, Humana Press, 2015. View at Publisher · View at Google Scholar
  18. G. L. Cromar, A. Zhao, A. Yang, and J. Parkinson, “Hyperscape: visualization for complex biological networks,” Bioinformatics, 2015. View at Publisher · View at Google Scholar
  19. J. A. Logan, M. E. Kelly, D. Ayers, N. Shipillis, G. Baier, and P. J. R. Day, “Systems biology and modeling in neuroblastoma: practicalities and perspectives,” Expert Review of Molecular Diagnostics, vol. 10, no. 2, pp. 131–145, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. T. Lehnert, S. Timme, J. Pollmächer, K. Hünniger, O. Kurzai, and M. T. Figge, “Bottom-up modeling approach for the quantitative estimation of parameters in pathogen-host interactions,” Frontiers in Microbiology, vol. 6, article 608, 2015. View at Publisher · View at Google Scholar
  21. Ó. Rolfsson and B. O. Palsson, “Decoding the jargon of bottom-up metabolic systems biology,” BioEssays, vol. 37, no. 6, pp. 588–591, 2015. View at Publisher · View at Google Scholar
  22. R. Breitling, D. Gilbert, M. Heiner, and R. Orton, “A structured approach for the engineering of biochemical network models, illustrated for signalling pathways,” Briefings in Bioinformatics, vol. 9, no. 5, pp. 404–421, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Stevens, C. De Leonibus, D. Hanson et al., “Network analysis: a new approach to study endocrine disorders,” Journal of Molecular Endocrinology, vol. 52, no. 1, pp. R79–R93, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. L. M. Edwards and I. Thiele, “Applying systems biology methods to the study of human physiology in extreme environments,” Extreme Physiology & Medicine, vol. 2, no. 1, article 8, 2013. View at Publisher · View at Google Scholar
  25. H. Fouladiha, S. Marashi, and M. A. Shokrgozar, “Reconstruction and validation of a constraint-based metabolic network model for bone marrow-derived mesenchymal stem cells,” Cell Proliferation, vol. 48, no. 4, pp. 475–485, 2015. View at Publisher · View at Google Scholar
  26. C. M. Andorf, V. Honavar, and T. Z. Sen, “Predicting the binding patterns of hub proteins: a study using yeast protein interaction networks,” PLoS ONE, vol. 8, no. 2, Article ID e56833, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. T. Çakır and M. J. Khatibipour, “Metabolic network discovery by top-down and bottom-up approaches and paths for reconciliation,” Frontiers in Bioengineering and Biotechnology, vol. 2, article 62, 2014. View at Publisher · View at Google Scholar
  28. H. C. Schramm and N. B. Dimitrov, “Differential equation models for sharp threshold dynamics,” Mathematical Biosciences, vol. 247, no. 1, pp. 27–37, 2014. View at Publisher · View at Google Scholar · View at Zentralblatt MATH · View at Scopus
  29. D. Barbolosi, A. Benabdallah, F. Hubert, and F. Verga, “Mathematical and numerical analysis for a model of growing metastatic tumors,” Mathematical Biosciences, vol. 218, no. 1, pp. 1–14, 2009. View at Publisher · View at Google Scholar · View at Zentralblatt MATH · View at Scopus
  30. E. Mora Van Cauwelaert, J. A. Arias Del Angel, M. Benítez, and E. M. Azpeitia, “Development of cell differentiation in the transition to multicellularity: a dynamical modeling approach,” Frontiers in Microbiology, vol. 6, article 603, 2015. View at Publisher · View at Google Scholar
  31. E. A. Sobie, “An introduction to dynamical systems,” Science Signaling, vol. 4, no. 191, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. A. Raue, B. Steiert, M. Schelker et al., “Data2Dynamics: a modeling environment tailored to parameter estimation in dynamical systems,” Bioinformatics, Article ID btv405, 2015. View at Publisher · View at Google Scholar
  33. D. Majumder and A. Mukherjee, “A passage through systems biology to systems medicine: adoption of middle-out rational approaches towards the understanding of therapeutic outcomes in cancer,” The Analyst, vol. 136, no. 4, pp. 663–678, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. A. Giuliani, S. Filippi, and M. Bertolaso, “Why network approach can promote a new way of thinking in biology,” Frontiers in Genetics, vol. 5, article 83, 2014. View at Publisher · View at Google Scholar · View at Scopus
  35. J. Costa, “Systems medicine in oncology,” Nature Clinical Practice Oncology, vol. 5, no. 3, article 117, 2008. View at Google Scholar
  36. M. Sarmady, W. Dampier, and A. Tozeren, “Sequence- and interactome-based prediction of viral protein hotspots targeting host proteins: a case study for HIV Nef,” PLoS ONE, vol. 6, no. 6, Article ID e20735, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Verma, E. G. Karimiani, R. J. Byers, S. Rehman, H. V. Westerhoff, and P. J. R. Day, “Mathematical modelling of miRNA mediated BCR.ABL protein regulation in chronic myeloid leukaemia vis-a-vis therapeutic strategies,” Integrative Biology, vol. 5, no. 3, pp. 543–554, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. W. Zhang, A. Edwards, W. Fan, E. K. Flemington, and K. Zhang, “MiRNA-mRNA correlation-network modules in human prostate cancer and the differences between primary and metastatic tumor subtypes,” PLoS ONE, vol. 7, no. 6, Article ID e40130, 2012. View at Publisher · View at Google Scholar · View at Scopus
  39. E. Albrecht, M. Waldenberger, J. Krumsiek et al., “Metabolite profiling reveals new insights into the regulation of serum urate in humans,” Metabolomics, vol. 10, no. 1, pp. 141–151, 2014. View at Publisher · View at Google Scholar · View at Scopus
  40. K. M. Mani, C. Lefebvre, K. Wang et al., “A systems biology approach to prediction of oncogenes and molecular perturbation targets in B-cell lymphomas,” Molecular Systems Biology, vol. 4, article 169, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. J. Faruque, C. F. Beaulieu, J. Rosenberg, D. L. Rubin, D. Yao, and S. Napel, “Content-based image retrieval in radiology: analysis of variability in human perception of similarity,” Journal of Medical Imaging, vol. 2, no. 2, p. 025501, 2015. View at Publisher · View at Google Scholar
  42. S. Benner, M. Kakeyama, T. Endo, W. Yoshioka, and C. Tohyama, “Application of NeuroTrace staining in the fresh frozen brain samples to laser microdissection combined with quantitative RT-PCR analysis,” BMC Research Notes, vol. 8, article 252, 2015. View at Publisher · View at Google Scholar
  43. N. E. Navin, “Delineating cancer evolution with single-cell sequencing,” Science Translational Medicine, vol. 7, no. 296, 2015. View at Publisher · View at Google Scholar
  44. S. Rehman, P. J. R. Day, A. Bayat, and H. V. Westerhoff, “Understanding Dupuytren's disease using systems biology: a move away from reductionism,” Frontiers in Physiology, vol. 3, article 316, 2012. View at Publisher · View at Google Scholar · View at Scopus
  45. S. Rehman, R. Goodacre, P. J. Day, A. Bayat, and H. V. Westerhoff, “Dupuytren's: a systems biology disease,” Arthritis Research and Therapy, vol. 13, no. 5, article no. 238, 2011. View at Publisher · View at Google Scholar · View at Scopus
  46. S. Rehman, F. Salway, J. K. Stanley, W. E. R. Ollier, P. Day, and A. Bayat, “Molecular phenotypic descriptors of Dupuytren’s disease defined using informatics analysis of the transcriptome,” Journal of Hand Surgery, vol. 33, no. 3, pp. 359–372, 2008. View at Publisher · View at Google Scholar · View at Scopus
  47. M. J. Bolt, F. Stossi, A. M. Callison, M. G. Mancini, R. Dandekar, and M. A. Mancini, “Systems level-based RNAi screening by high content analysis identifies UBR5 as a regulator of estrogen receptor-α protein levels and activity,” Oncogene, vol. 34, pp. 154–164, 2015. View at Publisher · View at Google Scholar · View at Scopus
  48. B. A. Kidd, L. A. Peters, E. E. Schadt, and J. T. Dudley, “Unifying immunology with informatics and multiscale biology,” Nature Immunology, vol. 15, no. 2, pp. 118–127, 2014. View at Publisher · View at Google Scholar · View at Scopus
  49. S. Zhao, T. Nishimura, Y. Chen et al., “Systems pharmacology of adverse event mitigation by drug combinations,” Science Translational Medicine, vol. 5, no. 206, 2013. View at Publisher · View at Google Scholar · View at Scopus
  50. J. J. Babcock, F. Du, K. Xu, S. J. Wheelan, and M. Li, “Integrated analysis of drug-induced gene expression profiles predicts novel hERG inhibitors,” PLoS ONE, vol. 8, no. 7, Article ID e69513, 2013. View at Publisher · View at Google Scholar · View at Scopus
  51. T. Pakladok, Z. Hosseinzadeh, A. Almilaji et al., “Up-regulation of hERG K+ channels by B-RAF,” PLoS ONE, vol. 9, no. 1, Article ID e87457, 2014. View at Publisher · View at Google Scholar · View at Scopus
  52. M. C. Cobanoglu, C. Liu, F. Hu, Z. N. Oltvai, and I. Bahar, “Predicting drug-target interactions using probabilistic matrix factorization,” Journal of Chemical Information and Modeling, vol. 53, no. 12, pp. 3399–3409, 2013. View at Publisher · View at Google Scholar · View at Scopus
  53. X. Chen, M.-X. Liu, and G.-Y. Yan, “Drug-target interaction prediction by random walk on the heterogeneous network,” Molecular BioSystems, vol. 8, no. 7, pp. 1970–1978, 2012. View at Publisher · View at Google Scholar · View at Scopus
  54. J. Tang and T. Aittokallio, “Network pharmacology strategies toward multi-target anticancer therapies: from computational models to experimental design principles,” Current Pharmaceutical Design, vol. 20, no. 1, pp. 23–36, 2014. View at Publisher · View at Google Scholar · View at Scopus
  55. G. Jin and S. T. C. Wong, “Toward better drug repositioning: prioritizing and integrating existing methods into efficient pipelines,” Drug Discovery Today, vol. 19, no. 5, pp. 637–644, 2014. View at Publisher · View at Google Scholar · View at Scopus
  56. G. Jin, C. Fu, H. Zhao, K. Cui, J. Chang, and S. T. C. Wong, “A novel method of transcriptional response analysis to facilitate drug repositioning for cancer therapy,” Cancer Research, vol. 72, no. 1, pp. 33–44, 2012. View at Publisher · View at Google Scholar · View at Scopus
  57. C. Fu, G. Jin, J. Gao, R. Zhu, E. Ballesteros-Villagrana, and S. T. C. Wong, “DrugMap central: an on-line query and visualization tool to facilitate drug repositioning studies,” Bioinformatics, vol. 29, no. 14, pp. 1834–1836, 2013. View at Publisher · View at Google Scholar · View at Scopus
  58. P. Mestdagh, S. Lefever, F. Pattyn et al., “The microRNA body map: dissecting microRNA function through integrative genomics.,” Nucleic acids research, vol. 39, no. 20, article e136, 2011. View at Publisher · View at Google Scholar · View at Scopus
  59. D. B. Kell, “Finding novel pharmaceuticals in the systems biology era using multiple effective drug targets, phenotypic screening and knowledge of transporters: where drug discovery went wrong and how to fix it,” FEBS Journal, vol. 280, no. 23, pp. 5957–5980, 2013. View at Publisher · View at Google Scholar · View at Scopus
  60. D. B. Kell, P. D. Dobson, E. Bilsland, and S. G. Oliver, “The promiscuous binding of pharmaceutical drugs and their transporter-mediated uptake into cells: ehat we (need to) know and how we can do so,” Drug Discovery Today, vol. 18, no. 5-6, pp. 218–239, 2013. View at Publisher · View at Google Scholar · View at Scopus
  61. D. B. Kell, “The virtual human: towards a global systems biology of multiscale, distributed biochemical network models,” IUBMB Life, vol. 59, no. 11, pp. 689–695, 2007. View at Publisher · View at Google Scholar · View at Scopus
  62. J. Petit, N. Meurice, C. Kaiser, and G. Maggiora, “Softening the rule of five—where to draw the line?” Bioorganic and Medicinal Chemistry, vol. 20, no. 18, pp. 5343–5351, 2012. View at Publisher · View at Google Scholar · View at Scopus
  63. S. Lefever, J. Hellemans, F. Pattyn et al., “RDML: structured language and reporting guidelines for real-time quantitative PCR data,” Nucleic Acids Research, vol. 37, no. 7, pp. 2065–2069, 2009. View at Publisher · View at Google Scholar · View at Scopus